Microfluidic Droplet Screening for Microbial Effector Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current screening methods for microorganisms producing compounds like amino acids or sugars are limited in their ability to analyze large libraries and detect effector molecules that influence growth behavior, as they do not allow for rapid analysis of microorganisms on a single cell level or in parallel, leading to difficulties in identifying strains with improved production properties.

Innovation Solution

A method using microfluidic devices to analyze microorganisms by introducing cells from a potential effector-producing microorganism and a detector microorganism into microdroplets for incubation, followed by analysis in a microfluidic system for growth effects, allowing for the identification of strains with inhibitory or enhancing effects on cell division.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional screening methods based on chromatography and mass spectroscopy are used, then detection accuracy of compounds is improved, but productivity and throughput are worsened due to limited parallelization capability

Engineering Contradiction:
Improvedetection accuracyVSAvoidthroughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The invention segments the screening process into individual microdroplets, each containing a single clone and detector microorganism. This segmentation enables parallel processing of thousands of clones simultaneously in a microfluidic system, dramatically increasing throughput while maintaining detection accuracy through isolated, controlled interactions in each droplet compartment.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from traditional bulk liquid chromatography to a microfluidic dimension, using microdroplets as reaction compartments. This dimensional change from macro-scale to micro-scale enables high-throughput parallel screening while preserving the sensitivity and accuracy of compound detection through confined, controlled environments in each droplet.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If biosensors expressing GFP or lux operon are used for detecting small molecules, then detection capability is improved, but the ability to rapidly analyze large libraries for effector molecules is worsened

Engineering Contradiction:
Improvedetection capabilityVSAvoidanalysis speed
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The invention segments the library analysis into individual microdroplets, each containing a single producer microorganism and detector microorganism. This enables parallel co-incubation of thousands of clones with detector strains, rapidly identifying effectors that stimulate or inhibit detector growth, thereby accelerating library screening while maintaining detection sensitivity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses detector microorganisms as intermediaries to indirectly detect effector molecules. Instead of directly measuring small molecule concentrations with biosensors, the detector microorganisms respond to effectors through growth stimulation or inhibition, providing a rapid, amplifiable signal that accelerates library analysis while preserving detection accuracy.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If microfluidic devices are used for single cell level analysis, then productivity and throughput are improved, but device complexity increases

Engineering Contradiction:
ImprovethroughputVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention employs a universal microfluidic droplet platform that handles multiple functions: clone encapsulation, detector microorganism introduction, co-incubation, and readout. This multi-functional system processes entire libraries through a single integrated workflow, increasing throughput while managing complexity through operational standardization and reusability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention creates numerous identical copies of the screening condition in the form of microdroplets, each containing a clone-detector pair. This copying approach parallelizes the analysis across thousands of droplets simultaneously, dramatically increasing throughput while using the same standardized protocol and reagents in each copy, thereby managing system complexity through repetition rather than variation.

Inventive Principle:
Principle #26Copying

Data Source

PatentUS11597963B2Microbial selection system
Publication Date: 2023.03.07 BIOMILLENIA SAS
  • US11597963B2 patent drawing
  • US11597963B2 patent drawing
  • US11597963B2 patent drawing

AI summary

The invention relates to a method for the identification of a first microorganism potentially secreting an effector compound, said first microorganism thereby having either i. an inhibitory effect on the cell division activity of a second microorganism or ii. an enhancing effect on the cell division activity of a second microorganism, the method comprising: a. providing a cell from a first microorganism which potentially produces an effector compound of interest and a cell from a second detector microorganism; b. introducing both cells into a microdroplet for incubation; c. introducing the microdroplet into a microfluidic system; d. analyzing in said microfluidic system the cell of the second microorganism for the exhibition of an enhanced growth effect or the exhibition of an inhibited growth effect stemming from said effector compound. The invention also relates to a microorganism or effector compound identified by the method according to the invention.